
AEON Biopharma fell 87.0% from $0.87 to $0.11, behind the S&P 500's +10.0%. Its worst day was Jul 13 (−33.3%), and its low came Nov 17 at $0.11.
Nov 17, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
AEON Biopharma shares rose 19.2%, while the S&P 500 fell 0.3%.
+19.2% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
AEON Biopharma closed at its highest level of the year, 56.3% above where the year started.
+13.3% · S&P 500 +1.2%
EPS of $-3.72 missed the $-0.26 estimate on $0.00 revenue.
−0.5% · S&P 500 +2.9%
EPS of $-0.29 beat the $-0.44 estimate on $0.00 revenue.
−9.9% · S&P 500 −1.2%
AEON Biopharma shares fell 33.3%, while the S&P 500 fell 0.8%.
−33.3%, the year's worst day · S&P 500 −0.8%
EPS of $-0.02 beat the $-0.33 estimate on $0.00 revenue.
−1.6% · S&P 500 +0.7%
AEON Biopharma shares rose 18.7%, while the S&P 500 rose 0.0%.
+18.7% · S&P 500 0.0%
AEON Biopharma shares rose 25.5%, while the S&P 500 fell 0.6%.
+25.5%, the year's best day, on 204M shares, the year's heaviest volume · S&P 500 −0.6%
AEON Biopharma shares fell 24.2%, while the S&P 500 fell 4.4%.
−24.2% · S&P 500 −4.4%
EPS of $0.01 beat the $-0.09 estimate on $0.00 revenue.
−19.4% · S&P 500 −1.0%
Where it ended: a close of $0.11 on Nov 17, 2026.
Nothing in the past 12 months.
All AEON dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AEON and SPY from Benzinga historical bars. Not investment advice.